Article ; Online: Alveolar lipids in pulmonary disease. A review.
Lipids in health and disease
2020 Volume 19, Issue 1, Page(s) 122
Abstract: Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is composed by multiple cell types with specialized functions and coordinately acting to meet specific physiologic requirements. The alveoli are the niche of the most ...
| Abstract | Lung lipid metabolism participates both in infant and adult pulmonary disease. The lung is composed by multiple cell types with specialized functions and coordinately acting to meet specific physiologic requirements. The alveoli are the niche of the most active lipid metabolic cell in the lung, the type 2 cell (T2C). T2C synthesize surfactant lipids that are an absolute requirement for respiration, including dipalmitoylphosphatidylcholine. After its synthesis and secretion into the alveoli, surfactant is recycled by the T2C or degraded by the alveolar macrophages (AM). Surfactant biosynthesis and recycling is tightly regulated, and dysregulation of this pathway occurs in many pulmonary disease processes. Alveolar lipids can participate in the development of pulmonary disease from their extracellular location in the lumen of the alveoli, and from their intracellular location in T2C or AM. External insults like smoke and pollution can disturb surfactant homeostasis and result in either surfactant insufficiency or accumulation. But disruption of surfactant homeostasis is also observed in many chronic adult diseases, including chronic obstructive pulmonary disease (COPD), and others. Sustained damage to the T2C is one of the postulated causes of idiopathic pulmonary fibrosis (IPF), and surfactant homeostasis is disrupted during fibrotic conditions. Similarly, surfactant homeostasis is impacted during acute respiratory distress syndrome (ARDS) and infections. Bioactive lipids like eicosanoids and sphingolipids also participate in chronic lung disease and in respiratory infections. We review the most recent knowledge on alveolar lipids and their essential metabolic and signaling functions during homeostasis and during some of the most commonly observed pulmonary diseases. |
|---|---|
| MeSH term(s) | 1,2-Dipalmitoylphosphatidylcholine/metabolism ; Humans ; Lipid Metabolism/genetics ; Lung/metabolism ; Lung/pathology ; Lung Diseases/genetics ; Lung Diseases/metabolism ; Lung Diseases/pathology ; Macrophages, Alveolar/metabolism ; Macrophages, Alveolar/pathology ; Pulmonary Alveoli/metabolism ; Pulmonary Alveoli/pathology ; Pulmonary Surfactants/metabolism ; Respiratory Distress Syndrome/genetics ; Respiratory Distress Syndrome/metabolism ; Respiratory Distress Syndrome/pathology |
| Chemical Substances | Pulmonary Surfactants ; 1,2-Dipalmitoylphosphatidylcholine (2644-64-6) |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-06-03 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ISSN | 1476-511X |
| ISSN (online) | 1476-511X |
| DOI | 10.1186/s12944-020-01278-8 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.